Orrin Pharma LLP
About Orrin Pharma LLP
Data last updated:
Orrin Pharma LLP is a limited liability partnership (LLP) based in Jabalpur, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 July 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Gwalior, under LLPIN AAE-3650. Its GSTIN is 23AAEFO4552H1ZF (Madhya Pradesh).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Sneha Budhrani and Sudhir Kumar Budhrani.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 2 – 4 Badi Omti Ghantaghar, Jabalpur, Madhya Pradesh, India – 482001.
As per MCA filings, the LLP has open charges of ₹12 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address2 – 4 Badi Omti Ghantaghar, Jabalpur, Madhya Pradesh, India – 482001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Orrin Pharma LLP FY 2025 filings available
Financial Statement Summary of Orrin Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Orrin Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Orrin Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Orrin Pharma LLP
Orrin Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sneha Budhrani | Designated Partner | 10 Jul 2015 | 11 Years 2 Months | Current |
| Sudhir Kumar Budhrani Also directs: Spranza Vita Pharmaceutical LLP, Real Water Fun Private Limited, Sudhir Life Sciences Private Limited and 3 more | Designated Partner | 10 Jul 2015 | 11 Years 2 Months | Current |
Charges & Borrowings of Orrin Pharma LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2015 | Hdfc Bank Limited | ₹12 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Orrin Pharma LLP
Employment history and EPFO contributions of people linked to Orrin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Orrin Pharma LLP
Orrin Pharma LLP has 2 designated partner changes on record since 2015: 2 appointments. The latest: Sneha Budhrani was appointed as Designated Partner on 10 Jul 2015.
Credit Ratings, Litigation & Regulatory Alerts for Orrin Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orrin Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orrin Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Orrin Pharma LLP
Orrin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAEFO4552H1ZF | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orrin Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orrin Pharma LLP
Orrin Pharma is an active limited liability partnership based in Jabalpur, Madhya Pradesh, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 10 July 2015 (11+ years old) and is registered under LLPIN AAE-3650.
Orrin Pharma has 2 current designated partners:
- Sneha Budhrani - Designated Partner
- Sudhir Kumar Budhrani - Designated Partner
The GSTIN of Orrin Pharma is 23AAEFO4552H1ZF, registered in Madhya Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Orrin Pharma is AAE-3650. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Orrin Pharma was incorporated on 10 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
Sneha Budhrani was appointed as Designated Partner on 10 Jul 2015. Sudhir Kumar Budhrani was appointed as Designated Partner on 10 Jul 2015.
The registered office of Orrin Pharma is at 2 – 4 Badi Omti Ghantaghar, Jabalpur, Madhya Pradesh, India – 482001.
The total obligation of contribution is ₹1 Lakh.
Orrin Pharma operates in the pharma industry, in the drug formulation and development segment.
Orrin Pharma has open charges of ₹12 Lakh and no satisfied charges on record as per latest MCA filings.